These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 20688285)

  • 1. Immunopotentiation of hepatitis B vaccine using biodegradable polymers as an adjuvant.
    Sivakumar SM; Sukumaran N; Nirmala L; Swarnalakshmi R; Anilbabu B; Siva L; Anbu J; Shanmugarajan TS; Ravichandran V
    J Microbiol Immunol Infect; 2010 Aug; 43(4):265-70. PubMed ID: 20688285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
    Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
    J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
    Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
    J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunogenicity of single-dose HBsAg-PLGA controlled release microspheres in mice].
    Feng L; Zhou XJ; Wang SC; Jiang Y; Qi XR
    Yao Xue Xue Bao; 2006 Feb; 41(2):132-7. PubMed ID: 16671543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D; Mangal S; Goswami R; Jaganathan KS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.
    Rajkannan R; Dhanaraju MD; Gopinath D; Selvaraj D; Jayakumar R
    Vaccine; 2006 Jun; 24(24):5149-57. PubMed ID: 16713035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS; Vyas SP
    Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Preparation, release and immunogenicity evaluation of HBsAg-PLGA microspheres].
    Feng L; Zhou XJ; Qi XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):527-31. PubMed ID: 16224529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
    Li Z; Xiong F; He J; Dai X; Wang G
    Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerosolized PLA and PLGA nanoparticles enhance humoral, mucosal and cytokine responses to hepatitis B vaccine.
    Thomas C; Rawat A; Hope-Weeks L; Ahsan F
    Mol Pharm; 2011 Apr; 8(2):405-15. PubMed ID: 21189035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of T helper type 1 immune responses against hepatitis B virus core antigen by PLGA nanoparticle vaccine delivery.
    Chong CS; Cao M; Wong WW; Fischer KP; Addison WR; Kwon GS; Tyrrell DL; Samuel J
    J Control Release; 2005 Jan; 102(1):85-99. PubMed ID: 15653136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen.
    Qiu S; Wei Q; Liang Z; Ma G; Wang L; An W; Ma X; Fang X; He P; Li H; Hu Z
    Hum Vaccin Immunother; 2014; 10(8):2350-6. PubMed ID: 25424942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).
    Fredriksen BN; Grip J
    Vaccine; 2012 Jan; 30(3):656-67. PubMed ID: 22100638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
    Prego C; Paolicelli P; Díaz B; Vicente S; Sánchez A; González-Fernández A; Alonso MJ
    Vaccine; 2010 Mar; 28(14):2607-14. PubMed ID: 20096389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan.
    Pandit S; Cevher E; Zariwala MG; Somavarapu S; Alpar HO
    J Microencapsul; 2007 Sep; 24(6):539-52. PubMed ID: 17654174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(vinyl alcohol)-coated chitosan microparticles act as an effective oral vaccine delivery system for hepatitis B vaccine in rat model.
    Shrestha B; Rath JP
    IET Nanobiotechnol; 2014 Dec; 8(4):201-7. PubMed ID: 25429498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on sustained release of human growth hormone from semi-crystalline poly(L-lactic acid) and amorphous poly(D,L-lactic-co-glycolic acid) microspheres: morphological effect on protein release.
    Kim HK; Park TG
    J Control Release; 2004 Jul; 98(1):115-25. PubMed ID: 15245894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle size influences the immune response produced by hepatitis B vaccine formulated in inhalable particles.
    Thomas C; Gupta V; Ahsan F
    Pharm Res; 2010 May; 27(5):905-19. PubMed ID: 20232117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
    Feng L; Qi XR; Zhou XJ; Maitani Y; Wang SC; Jiang Y; Nagai T
    J Control Release; 2006 May; 112(1):35-42. PubMed ID: 16516999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.